查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1528121

世界人造器官市场

Artificial Organs
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 288 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，美国的全球人造器官市场将达到 432 亿美元

2023年全球人造器官市场估计为260亿美元，预计到2030年将达到432亿美元，2023-2030年分析期间复合年增长率为7.5%。人工肾臟是本报告分析的细分市场之一，预计复合年增长率为 8.1%，到分析期结束时将达到 231 亿美元。分析期间，人工胰臟细分市场的复合年增长率预计为 7.1%。

美国市场预计69亿美元，中国预计复合年增长率7.0%

预计 2023 年美国人造器官市场规模将达 69 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达67亿美元，2023-2030年分析期间复合年增长率为7.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 6.8% 和 6.2%。在欧洲，德国预计复合年增长率为 5.7%。

全球人造器官市场 - 主要趋势和驱动因素总结

仿生人：仍然是想像中的虚构人物，但正在缓慢而坚定地接近

想像一个仿生人走在我们中间的世界，不仅出现在科幻电影的闪烁画面中，也成为我们日常生活现实的一部分。每当人造心臟跳动和人造肺部呼吸时，这现代科学奇蹟都反映了人类生物学的复杂交响曲。这个「人造器官」曾经只是他实验室白板上的草图，现在却在他体内充满了生命。他的血管里流动着实验室培养的血液，他的眼睛清晰可见，只有高清摄影机才能提供，他的指尖被设计成模仿人类皮肤的柔软度，可以轻轻地触摸。人工器官科学正在透过奇蹟般的创新将这个梦想变成现实。

什么是人造器官？

人工器官是一种仿生装置，植入或整合到人体中，以取代故障的自然器官，恢復特定功能或功能集，使患者恢復正常生活。这些包括人造心臟、人造肾臟、人造肝臟以及最近的生物人造胰臟和人造血管。人造器官的开发是一个复杂的多学科领域，结合了生物医学工程、材料科学和细胞生物学的进步。此类设备的整合可以显着改善器官衰竭患者的生活品质并延长其寿命。鑑于全球器官捐赠者短缺以及与糖尿病和心臟病等慢性疾病相关的器官衰竭发生率不断增加，这一点尤其重要。

科技如何推进人造器官的功能？

技术进步是人工器官发展演化的核心。现代人造器官越来越多地采用先进的生物材料，这些材料具有生物相容性并且能够执行复杂的生物功能。例如，在心臟瓣膜和血管中使用先进的聚合物和复合材料可以模仿人体组织的自然弹性和强度，降低血栓的风险并延长寿命。此外，3D生物列印的发展正在突破器官替代可能性的界限，使得列印复杂的组织和器官结构成为可能。这些技术不仅提高了人造器官的性能，还降低了排斥反应和其他与移植相关的併发症的併发症。

人造器官在医学领域面临哪些挑战？

儘管取得了重大进展，但将人造器官融入医学仍面临一些挑战。其中最主要的是身体排斥异物的倾向，这可能导致严重的併发症和设备故障。这需要持续服用药物来抑制免疫系统，从而带来长期的健康风险。此外，人造器官的耐用性和功能可能与天然器官不完全匹配，这会影响患者的生活品质。此外，开发和实施的高昂成本使得这些技术对于许多需要它们的人来说遥不可及。此外，必须克服道德和监管障碍，以确保新设备安全有效。应对这些挑战需要持续的研究和创新，以及能够跟上技术进步的全面法律规范。

推动人造器官市场成长的因素有哪些？

人造器官市场的成长受到多种因素的推动，包括提高这些设备的有效性和安全性的技术创新。糖尿病和心臟病等导致器官衰竭的慢性疾病的盛行率不断上升，推动了世界各地对人造器官的需求。这是因为已开发国家的人口正在老化，老年人更有可能患上需要器官置换的疾病。此外，医疗基础设施的改善和全球医疗支出的增加使更多人更容易获得这些先进的治疗方法。新兴市场的经济发展正进一步扩大人造器官市场范围，提供新的就业机会。最后，器官捐赠可用性的持续挑战继续推动对替代解决方案的需求，并推动人造器官产业的成长，以满足世界各地患者的关键需求。

受访企业范例（71家知名企业）

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第四章 比赛

简介目录
Product Code: MCP-1126

Global Artificial Organs Market to Reach US$43.2 Billion by 2030

The global market for Artificial Organs estimated at US$26.0 Billion in the year 2023, is expected to reach US$43.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Artificial Kidneys, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$23.1 Billion by the end of the analysis period. Growth in the Artificial Pancreas segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 7.0% CAGR

The Artificial Organs market in the U.S. is estimated at US$6.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Artificial Organs Market - Key Trends and Drivers Summarized

The Bionic Man: Still a Figment of Our Imagination, but We Are Getting There Slowly and Decisively

Imagine a world where the bionic man walks among us, not just in the flickering frames of a sci-fi film but as a part of our everyday reality. With each beat of his engineered heart and each breath drawn by synthetic lungs, this marvel of modern science mirrors the intricate symphony of human biology. Artificial organs, once mere sketches on research lab whiteboards, now pulse with life within him. His veins course with lab-crafted blood, his eyes see with the clarity only high-definition cameras can provide, and his touch is gentle with fingers engineered to mimic the softness of human skin. While the true incarnation of the bionic man remains nestled in the realm of future possibilities, the science of artificial organs is knitting this dream into the fabric of the probable, one miraculous innovation at a time.

What Are Artificial Organs, and How Are They Changing Lives?

Artificial organs are bioengineered devices that are implanted or integrated into human bodies to replace natural organs that have failed, restoring a specific function or a group of related functions to help the patient return to a normal life. These include artificial hearts, kidneys, livers, and more recently, bioartificial pancreases and synthetic blood vessels. The development of artificial organs is a complex, interdisciplinary field that combines advancements in biomedical engineering, materials science, and cellular biology. The integration of such devices can significantly improve the quality of life and extend the lifespan of individuals suffering from organ failure. This is especially critical given the global shortage of organ donors and the increasing incidence of organ failure linked to chronic diseases such as diabetes and heart disease.

How Is Technology Advancing the Functionality of Artificial Organs?

Technological advancements are at the core of the evolution in artificial organ development. Modern artificial organs are increasingly incorporating advanced biomaterials that are biocompatible and can perform complex biological functions. For instance, the use of cutting-edge polymers and composite materials in heart valves and blood vessels can mimic the natural elasticity and strength of human tissue, reducing the risk of blood clots and improving longevity. In addition, developments in 3D bioprinting are pushing the boundaries of what's possible in organ replacement, allowing for the printing of complex tissues and organ structures that could one day lead to fully functional, biologically active organs. These technologies not only enhance the performance of artificial organs but also reduce the risk of rejection and other complications associated with transplants.

What Challenges Do Artificial Organs Face in Medical Practice?

Despite significant advancements, the integration of artificial organs into medical practice faces several challenges. The foremost is the body's tendency to reject foreign objects, which can lead to serious complications or device failure. This necessitates ongoing medication regimes to suppress the immune system, posing long-term health risks. Additionally, the durability and functionality of artificial organs may not fully match those of their natural counterparts, which can affect the patient's quality of life. There is also the high cost of development and implementation, making these technologies inaccessible to many who need them. Furthermore, ethical and regulatory hurdles must be navigated to ensure that new devices are both safe and effective. Addressing these challenges requires continuous research and innovation, as well as comprehensive regulatory frameworks that can keep pace with technological advancement.

What Drives the Growth in the Artificial Organs Market?

The growth in the artificial organs market is driven by several factors, including technological innovations that enhance the effectiveness and safety of these devices. The rising prevalence of chronic diseases that lead to organ failure, such as diabetes and heart disease, is increasing the demand for artificial organs worldwide. Aging populations in developed countries also contribute to this demand, as older age groups are more likely to suffer from conditions requiring organ replacement. Additionally, improvements in healthcare infrastructure and increased healthcare spending globally make these advanced treatments more accessible to a broader audience. Economic development in emerging markets further expands the reach of the artificial organs market, providing new opportunities for adoption. Lastly, the ongoing challenges in donor organ availability continue to push the need for alternative solutions, bolstering the growth of the artificial organs industry as it works to meet the critical needs of patients worldwide.

Select Competitors (Total 71 Featured) -

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Artificial Organs - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technological Breakthroughs in Biomaterials and Biocompatibility Expand Market Opportunities
    • Rising Incidence of Organ Failure and Limitations in Donor Availability Propel Demand
    • Advances in 3D Printing and Bioprinting Technologies Strengthen Market Potential
    • Growth in Healthcare Expenditure and Investments in Advanced Medical Technologies
    • Innovations in Artificial Heart and Kidney Devices Set the Stage for Growth
    • Ethical and Moral Challenges Impacting the Adoption of Artificial Organs
    • Technological Convergence in Robotics, Nanotechnology, and Biomedicine
    • Advances in Sensory and Feedback Technologies for Prosthetics and Implants
    • Innovations in Immunosuppression and Post-transplant Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Organs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Artificial Kidneys by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Artificial Pancreas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Artificial Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Artificial Lungs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • JAPAN
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • CHINA
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • EUROPE
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • FRANCE
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • GERMANY
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 56: Rest of World Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of World Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of World 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030

IV. COMPETITION